Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Sep 2017 14:39

RNS Number : 9986R
Silence Therapeutics PLC
27 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Silence Therapeutics PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

ING Groep N.V.

City and country of registered office (if applicable)

Amsterdam / Netherlands

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

26-09-2017

6. Date on which issuer notified (DD/MM/YYYY):

27-09-2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.58%

5.58%

69,991,624

Position of previous notification (if

applicable)

6.07%

6.07%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B9GTXM62

3,905,674

5.58%

SUBTOTAL 8. A

3,905,674

5.58%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

ING Groep N.V.

5.58%

5.58%

ING Bank N.V.

5.58%

5.58%

10. In case of proxy voting, please identify:

Name of the proxy holder

n.a.

The number and % of voting rights held

n.a.

The date until which the voting rights will be held

n.a.

11. Additional informationxvi

 

Place of completion

Amsterdam

Date of completion

27 September 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBOORBNAKUAR
Date   Source Headline
22nd Oct 200712:49 pmPRNHolding(s) in Company
9th Oct 200710:58 amPRNIssue of Equity
2nd Oct 20071:30 pmPRNDirector/PDMR Shareholding
28th Sep 20077:00 amPRNHalf-yearly Report
26th Sep 200711:28 amPRNHolding(s) in Company
10th Sep 20077:00 amPRNResearch Update
6th Sep 20077:05 amPRNNotice of Results
4th Sep 20077:30 amPRNHolding(s) in Company
24th Aug 20074:10 pmPRNHolding(s) in Company
23rd Aug 200712:45 pmPRNHolding(s) in Company
20th Aug 20071:08 pmPRNHolding(s) in Company
16th Aug 200710:12 amPRNHolding(s) in Company
15th Aug 20073:25 pmPRNAIM Rule 26
15th Aug 20072:52 pmPRNHolding(s) in Company
9th Aug 20072:18 pmPRNHolding(s) in Company
9th Aug 20077:01 amRNSHolding(s) in Company
2nd Aug 20073:53 pmPRNHolding(s) in Company
2nd Aug 200710:55 amPRNResult of AGM
31st Jul 200710:27 amPRNTotal Voting Rights
31st Jul 20077:00 amPRNRe Agreement
27th Jul 20077:00 amPRNDirectorate Change
27th Jul 20077:00 amPRNDirectorate Change
20th Jul 200711:35 amPRNHolding(s) in Company
13th Jul 20074:09 pmPRNHolding(s) in Company
11th Jul 20073:37 pmPRNHolding(s) in Company
10th Jul 200712:56 pmPRNHolding(s) in Company
9th Jul 20072:27 pmPRNNotice of AGM
9th Jul 200711:01 amPRNHolding(s) in Company
6th Jul 20074:51 pmPRNIssue of Equity
6th Jul 20071:00 pmPRNRe Agreement
2nd Jul 20074:06 pmPRNIssue of Equity
29th Jun 20077:00 amPRNAnnual Report and Accounts
26th Jun 200711:33 amPRNTotal Voting Rights
21st Jun 20073:28 pmPRNHolding(s) in Company
20th Jun 20071:55 pmPRNCorrection : Holding(s) in Company
15th Jun 20077:00 amRNSConference Attendance
14th Jun 20077:00 amPRNIssue of Equity
13th Jun 20073:20 pmPRNHolding(s) in Company
6th Jun 200711:15 amPRNHolding(s) in Company
30th May 20077:05 amPRNHolding(s) in Company
29th May 20074:20 pmPRNHolding(s) in Company
29th May 200710:44 amPRNHolding(s) in Company
21st May 20073:37 pmPRNIssue of Equity
11th May 20074:26 pmPRNHolding(s) in Company
9th May 200711:45 amPRNIssue of Equity
4th May 20077:01 amRNSSR Pharma Name Change
30th Apr 20071:50 pmPRNTotal Voting Rights
26th Apr 200710:30 amPRNEGM Statement & Research Update
23rd Apr 20077:05 amPRNIssue of Equity
3rd Apr 20079:45 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.